How much does Naxitamab injection cost?

Naxitamab injection (Naxitamab) is used in combination with another medicine in adults and children 1 year and older to treat neuroblastoma (a cancer that starts in nerve cells) that has come back in the bone or bone marrow or has not responded to previous treatments but has responded to other treatments. Noxetuzumab injection belongs to a class of drugs called monoclonal antibodies, which work by killing cancer cells.

Nasitumumab injection is a solution (liquid) that is injected intravenously (into a vein) over 30 to 60 minutes by a doctor or nurse at a medical facility or infusion center. It is typically administered on days 1, 3, and 5 of a 28-day treatment cycle and may be repeated based on patient response. After initial treatment, your doctor may prescribe additional treatment cycles every 8 weeks. Your doctor may prescribe other medications before and during each dose to help prevent certain side effects.

During treatment, the doctor may need to temporarily or permanently stop the patient's treatment or reduce the dose of cerebrospinal fluid, but this depends on the drug's efficacy for the patient and the side effects experienced. The most common adverse reactions (incidence ≥25%) in patients receiving nocetumumab injection were infusion-related reactions, pain, tachycardia, vomiting, cough, nausea, diarrhea, decreased appetite, hypertension, fatigue, erythema multiforme, peripheral neuropathy, urticaria, pyrexia, headache, injection site reactions, edema, anxiety, focal edema, and irritability.

It is understood that noxituzumab injection has been approved in China, but it has not been included in medical insurance. Its price is still unclear and the purchase method is difficult. The original drug of Naxituzumab injection marketed overseas is very expensive, and the price may fluctuate due to exchange rates. For more drug information and specific prices, please consult a medical consultant.